Nine new members appointed to America’s Advisory Committee on Immunization Practices (ACIP) have financial ties to Big Pharma, or have publicly promoted vaccines.

New appointees to US vaccine advisory committee have ties to Big Pharma 

ACIP is said to be an autonomous group of experts not affiliated with the federal government.

Children’s Health Defense reported on Wednesday massive conflict of interest concerns for the new appointees who will be advising the Centers for Disease Control and Prevention (CDC) on vaccine recommendations. 

The report points out that most of the appointees have received grant funding or consulting fees from major pharmaceutical companies like Pfizer, Moderna, and Merck:

  • Dr. Denise Jamieson: Known for promoting COVID vaccines for pregnant women and receiving funding from the CDC for COVID-19 vaccination promotion.
  • Dr. Yvonne Maldonado: Received research funding from Pfizer and advocated for testing COVID vaccines in children.
  • Dr. Robert Schechter: Serves as a public advocate on various HHS committees and has a background with the California Department of Public Health.
  • Dr. Albert Shaw: Advocated for COVID-19 vaccination and has ties to pharmaceutical companies.
  • Dr. Edwin Asturias: A global vaccine researcher with consulting fees from major pharmaceutical companies like Merck.
  • Dr. Noel Brewer: Known for developing the “Announcement Approach” to HPV vaccination and consulting for Merck.
  • Dr. Helen Chu: Has ties to pharmaceutical companies, Gates ventures, and advocates for the RSV vaccine.

The cozy relationship between Big Pharma and vaccine safety advisors isn’t anything new, of course. In December 2022, a member from Pfizer’s Independent Data Safety Monitoring Board admitted in court that she was also on the pharmaceutical company’s payroll. 

FDA removes informed consent for “minimal risk” 

Last month, the Food and Drug Administration’s (FDA) removed the requirement to get informed consent from human participants for what they call “minimal risk” studies.

The FDA claimed the policy change will provide cost savings and healthcare advances. 

Share this story

Donate now to keep us on the front lines:

Help Keep your News Free

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

A growing amount of illegal contraband is being sold online and shipped across Canada, a new report has found. 

Walid Tamtam

January 10, 2025

Trending News

A cop who is being unfairly punished for investigating whether COVID-19 vaccines were killing infants has filed a lawsuit against the CBC for allegedly harassing and misrepresenting her.

Keean Bexte

January 9, 2025

Trending News

The Online Harms Act (Bill C-63) and many other censorship bills have been stopped dead in their tracks due to Trudeau’s prorogation of Parliament.

Keean Bexte

January 7, 2025

Trending News

U.S. President-elect Donald Trump used Trudeau’s decision to suspend democracy by proroguing Parliament to float the idea of merging Canada with the U.S.

Keean Bexte

January 6, 2025

Trending News

Liberal MP Iqra Khalid suggested that she would never know if Russia funded Jordan Peterson’s podcast with Pierre Poilievre since Poilievre hadn’t gotten his ‘security clearance.’

Walid Tamtam

January 4, 2025

Trending News

Conservatives move to force non-confidence vote as soon as the House of Commons resumes late January. Will Trudeau prorogue parliament to avoid it?

TCS Wire

December 27, 2024

Want to join the conversation?

Sign up now to be able to like, comment and reply to other members. A full membership to our site includes:

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.